You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BCR Abl kinase inhibitor

Showing 1 - 25 of 8,616
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

Recruiting
  • CML
  • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
  • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
    FUNDALEU
Jun 29, 2023

Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia Trial in Houston (Asciminib)

Recruiting
  • Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2022

Tyrosine Kinase Inhibitor in Chronic Myeloid Leukemia

Not yet recruiting
  • Tyrosine Kinase Inhibitor
  • +2 more
    • Taipei, Taiwan
      National Taiwan University Hospital
    Feb 17, 2022

    Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia Trial in Philadelphia (Text

    Recruiting
    • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • Chronic Phase Chronic Myelogenous Leukemia
    • Text Message-Based Navigation Intervention
    • Survey Administration
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Apr 7, 2022

    Condition Vasoregulation Function Endothelium in CML Getting TKI

    Recruiting
    • Chronic Myeloid Leukaemia
    • taking blood for the study of biochemical parameters and the study of microcirculation using the method of laser Doppler flowmetry
    • Moscow, Russian Federation
    • +1 more
    Jan 11, 2023

    CML (Chronic Myelogenous Leukemia Trial (KDS-1001)

    Not yet recruiting
    • CML (Chronic Myelogenous Leukemia
    • (no location specified)
    Jul 27, 2022

    Chronic Leukemia Trial in France (Additional biological samples)

    Active, not recruiting
    • Chronic Leukemia
    • Additional biological samples
    • Besançon, France
    • +3 more
    May 31, 2022

    TKI Discontinuation in CML Patients of China

    Recruiting
    • Leukemia
    • +4 more
      • Shenzhen, Guangdong, China
        Shenzhen Second People's Hospital
      Mar 15, 2022

      Ovarian Reserve and Fertility in Chronic Myeloid Leukemia or

      Recruiting
      • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +2 more
      • Cytology Specimen Collection Procedure
      • +3 more
      • Los Angeles, California
        USC / Norris Comprehensive Cancer Center
      Nov 16, 2021

      Outcomes of Tyrosine Kinase Inhibitor(TKI)Stopping in Chronic

      Recruiting
      • Folate
      • +2 more
        • Nantong, China
          Affliated Hospital of Nantong University
        Dec 13, 2021

        Chronic Myeloid Leukemia, Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission, Chronic Myeloid Leukemia in Remission Trial

        Recruiting
        • Chronic Myeloid Leukemia
        • +2 more
        • Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Withdrawal
        • Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Re-initiation
        • Houston, Texas
        • +3 more
        Jan 25, 2022

        Chronic Phase Chronic Myeloid Leukemia Trial in Tampa (Nilotinib, Ruxolitinib)

        Completed
        • Chronic Phase Chronic Myeloid Leukemia
        • Tampa, Florida
          H. Lee Moffitt Cancer Center and Research Institute
        Jan 4, 2021

        Innate CD8+ T Cells and Evolution of Tyrosine Kinase Inhibitor

        Recruiting
        • Leukemia
        • +3 more
        • Phenotyping of total and innate CD8+T cells by flow cytometry
        • Nîmes, Gard, France
          CHU de Nîmes
        Jul 19, 2021

        Myeloproliferative Tumor, Chronic Phase Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (Online

        Recruiting
        • Myeloproliferative Neoplasm
        • +2 more
        • Online Mindfulness Meditation
        • Internet-Based Webinars
        • San Francisco, California
          University of California San Francisco
        Aug 9, 2022

        Leukemia, Myeloid, Chronic-Phase Trial in Germany (Ponatinib)

        Active, not recruiting
        • Leukemia, Myeloid, Chronic-Phase
        • Halle (Saale), Saxony-Anhalt, Germany
        • +9 more
        Sep 9, 2022

        Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL

        Active, not recruiting
        • Chronic Phase Chronic Myeloid Leukemia
          • Chicago, Illinois
          • +24 more
          May 24, 2021

          Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

          Completed
          • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
          • +4 more
          • Eltrombopag Olamine
          • Houston, Texas
            M D Anderson Cancer Center
          Jan 4, 2022

          Chronic Phase Chronic Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia, Blastic Phase Chronic Myeloid Leukemia Trial

          Completed
          • Chronic Phase Chronic Myeloid Leukemia
          • +4 more
          • Toronto, Ontario, Canada
            Princess Margaret Hospital / University Health Network
          Oct 29, 2020

          Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

          Recruiting
          • Chronic Phase Chronic Myelogenous Leukemia
          • +3 more
          • Houston, Texas
            M D Anderson Cancer Center
          Aug 11, 2022

          Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission, Minimal Residual

          Terminated
          • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
          • +3 more
          • Houston, Texas
            M D Anderson Cancer Center
          Dec 1, 2020

          Philadelphia Positive, BCR-ABL Positive, Acute Lymphoblastic Leukemia Trial in Italy (Ponatinib)

          Completed
          • Philadelphia Positive
          • +2 more
          • Alessandria, Italy
          • +41 more
          Nov 18, 2021

          Information of Ponatinib, Bosutinib, Imatinib, Dasatinib and

          Completed
          • Leukemia
          • No Intervention
          • Cambridge, Massachusetts
            Takeda
          Feb 28, 2023

          Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)

          Terminated
          Has Results
          • Chronic Myeloid Leukemia
          • Omacetaxine mepesuccinate
          • Jacksonville, Florida
          • +9 more
          Nov 6, 2021

          Tyrosine Kinase Inhibitors, Chronic Myeloid Leukemia Trial in Poitiers (treatment of TKI in CML)

          Not yet recruiting
          • Tyrosine Kinase Inhibitors
          • Chronic Myeloid Leukemia
          • treatment of TKI in CML
          • Poitiers, France
            Chu Poitiers
          Feb 21, 2023

          Leukemia, Chronic Myeloid Trial in Ann Arbor, Winston-Salem (Nilotinib, Ruxolitinib)

          Withdrawn
          • Leukemia, Chronic Myeloid
          • Ann Arbor, Michigan
          • +1 more
          Feb 11, 2021